对牛皮的创新方法:小分子准关键信号通路
Meeral Gosia1, Gaurav Doshi1, Siddhi Bagwe Parab1
1Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, India.
Immunological investigations
|January 17, 2025
概括
小分子通过准关键信号通路,为治疗牛皮提供了一种新的方法. 该策略旨在改善患者的治疗结果,并减少与当前生物疗法相比的副作用.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种慢性,免疫媒介的皮肤疾病,由炎症和角质细胞过度增殖驱动.
- 针对IL-17和IL-23的生物药物改善了牛皮的治疗,但需要持续的管理和监测.
- 生物制剂的局限性凸显了对替代治疗策略的需求.
研究的目的:
- 探索小分子作为牛皮的新治疗策略.
- 为了研究在牛皮病理病理学中信号通路的作用.
- 了解小分子如何调节这些途径以改善治疗.
主要方法:
- 关于牛皮病理病理学的当前文献的综述.
- 分析与炎症性皮肤疾病相关的信号通路.
- 探索针对这些途径的小分子抑制剂.
主要成果:
- 小分子选择性地抑制了与牛皮有关的关键信号通路.
- 这种方法为生物制剂提供了一个潜在的替代品,具有更好的耐受性.
- 量身定制的小分子抑制剂可能会导致个性化的牛皮治疗计划.
结论:
- 小分子代表了 psoriasis 管理的有希望的新范式.
- 针对特定的分子通路可以提高治疗效率.
- 对小分子抑制剂的进一步研究可以改善患者的生活质量.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Cell-surface Signaling
51.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


